Search results for "LIGA"

showing 10 items of 3556 documents

Ureteral injury during left colectomy for cancer: Laparoscopic management. A case report

2020

Abstract Introduction Iatrogenic ureteral lesions may occur after any abdominal and pelvic surgery. They are severe and can affect renal function and even vital prognosis. This study aimed to determine the clinical aspects and the therapeutic approaches of a lower third injury of the ureter during a laparoscopic left colectomy. Presentation of case An 81 year-old-man with left-sided colon cancer underwent laparoscopic left colectomy. During surgery there was a continuous full-thickness solution of the left ureter for which an end-to-end ureteral anastomosis was performed. In the postoperative period the patient underwent multiple urological and radiological interventional procedures due to …

medicine.medical_specialtymedicine.medical_treatmentIschemiaCase ReportAnastomosisurologic and male genital diseases03 medical and health sciences0302 clinical medicineUreterUreteral lesionmedicineLaparoscopyGynecological surgerymedicine.diagnostic_testbusiness.industryUretero-ureteral anastomosisStentmedicine.diseaseSurgeryIntracorporeal laparoscopic suturesmedicine.anatomical_structure030220 oncology & carcinogenesisLaparoscopic left colectomyIatrogenic ureteral lesion030211 gastroenterology & hepatologySurgeryPresentation (obstetrics)businessLigationInternational Journal of Surgery Case Reports
researchProduct

Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What Have We Learned?

2020

In 2007, the first associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure was performed in Regensburg, Germany. ALPPS is a variation of two-stage hepatectomy to induce rapid liver hypertrophy allowing the removal of large tumors otherwise considered irresectable due to a too small future liver remnant. In 2012, the international ALPPS registry was created, and it now contains more than 1,000 cases. During the past years, improved patient selection and refinements in operative techniques, in particular, less invasive approaches such as Partial ALPPS, Tourniquet ALPPS, Ablation-assisted ALPPS, Hybrid ALPPS or Laparoscopic or Robotic approaches, have resu…

medicine.medical_specialtymedicine.medical_treatmentLess invasivePortal vein ligationReviewResection03 medical and health sciences0302 clinical medicineCarcinomaHepatectomyHumansMedicineRegistriesPerihilar CholangiocarcinomaRandomized Controlled Trials as TopicTwo-stage hepatectomyALPPS registryHepatologyPortal Veinbusiness.industryCarcinoma hepatocellularLiver NeoplasmsGastroenterologymedicine.diseaseSurgeryTreatment OutcomeBile Duct NeoplasmsLiver030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyALPPSOutcome dataHepatectomyPerihilar cholangiocarcinomabusinessGut and Liver
researchProduct

Outpatient Treatment of Hemorrhoidal Disease: The Alternative Way to Treat Hemorrhoidal Disease in a Simple, Safe and Effective Manner.

2021

Background:: Hemorrhoidal disease is a widespread problem in healthy working patients. The traditional surgical approaches cause a loss of several working days related to the post-- operative course that is often painful. To avoid these problems while offering a symptoms resolution in patients with low degrees hemorrhoids, the non-surgical treatments are nowadays largely proposed in proctological clinics. Methods: We resume the recent literature on the issue to offer a practical and easy to use guide for clinicians. Results: Rubber band ligation, injection sclerotherapy and infrared coagulation are cost effective, safe and effective treatments for patients with II- and III-degree hemorrhoi…

medicine.medical_specialtymedicine.medical_treatmentReviewInfrared coagulationRubber band ligationHemorrhoidsHemorrhoid ligationHemorroid infrared coagulationHemorrhoidal diseaseHemorrhoidsInjection sclerotherapyOutpatientsSclerotherapymedicineHumansIn patientIntensive care medicineLigationPharmacologySurgical approachbusiness.industryGeneral Medicinemedicine.diseaseHemorroid complicationTreatment OutcomeDisease cureOutpatient treatmentQuality of LifeHemorrhoid sclerotherapybusinessReviews on recent clinical trials
researchProduct

Identification of normal and pathological posterior inter-malleolar ligament with dedicated high-field vs low-field MRI. A pilot study

2015

AIM the aim of the study was to determine an objective measure of detection of posterior inter-malleolar ligament (PIML) through a magnetic resonance (MRI) of the ankle with two dedicated scanners: high-field (1-Tesla: HMF) and low-field (0.2-Tesla: LMF). METHODS two-hundred subjects were randomly recruited for the study and then divided in two groups (HMF and LMF). We retrospectively evaluated the MRI of the ankle in the two groups of patients. PIML evaluation was performed globally and separately using different scan planes. RESULTS in HMF and LMF, the PIML was identified respectively in 55 and 11% of cases. PIML was classified as "indeterminate" in 28 and 57% of patients, and "absent" in…

medicine.medical_specialtymusculoskeletalmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingLow field mriSagittal planeSurgerymagnetic resonancemedicine.anatomical_structureligamentCoronal planeankleLigamentmedicineOriginal ArticleOrthopedics and Sports MedicineHigh fieldAnkleNuclear medicinebusinessPathologicalMuscle Ligaments and Tendons Journal
researchProduct

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

2015

Abstract: Introduction: The identification of cell membrane-bound molecules with a relevant role in cancer cell survival prompted the development of moAbs to block the related pathways. In the last few years, the number of approved moAbs for cancer treatment has constantly increased. Many of these drugs significantly improved the survival outcomes in patients with solid tumours. Areas covered: In this review, all the FDA-approved moAbs in solid tumours have been described. This is an update of moAbs available for cancer treatment nowadays in comparison with the moAbs approved until few years ago. The moAbs under development are also discussed here. Expert opinion: The research on cancer ant…

medicine.medical_treatmentClinical BiochemistryCellReceptor activator of nuclear factor κB ligandCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)NeoplasmsMonoclonalDrug DiscoveryDrug approvalCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all); Cancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)Drug ApprovalCancerbiologyMedicine (all)Antibodies MonoclonalVEGFReceptor activator of nuclear factor κB ligandmedicine.anatomical_structureMonoclonalMoAbsImmunotherapyAntibodyEngineering sciences. TechnologyHumanUnited StateCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)medicine.drug_classEGFRMonoclonal antibodyAntibodiesCancer antigenCytotoxic T-lymphocyte antigen 4HER2medicineHumansBiologyPharmacologybusiness.industryUnited States Food and Drug AdministrationDrug Discovery3003 Pharmaceutical ScienceCancerImmunotherapymedicine.diseaseUnited StatesImmunologyCancer cellCancer researchbiology.proteinNeoplasmMoAbHuman medicinebusinessExpert opinion on biological therapy
researchProduct

Histological study of human periodontal tissue following biologically oriented preparation technique (BOPT)

2020

Background The aim of this study was to conduct histological analysis of a human tooth resected with the periodontal insertion apparatus intact following treatment using biologically oriented preparation technique (BOPT). Material and methods This descriptive histological dento-periodontal study used an anterior tooth extracted with the surrounding periodontal tissues intact, following prosthetic restoration with BOPT. The sample patient was recruited from among those attending the Department of Dental Medicine at the Faculty of Medicine and Dentistry, University of Valencia (Spain). Eight serial sections of the restored tooth were processed. The relative location and histological character…

medicine.medical_treatmentJunctional epitheliumDentistryConnective tissueCase Report02 engineering and technologyCrown (dentistry)03 medical and health sciences0302 clinical medicinestomatognathic systemHuman toothmedicineGeneral DentistryProsthetic Dentistrybusiness.industrySulcular epithelium030206 dentistryPeriodontium021001 nanoscience & nanotechnology:CIENCIAS MÉDICAS [UNESCO]Cementoenamel junctionstomatognathic diseasesmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASLigament0210 nano-technologybusiness
researchProduct

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma

2017

Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous and aggressive tumor originating from the epithelial lining of the upper aero-digestive tract accounting for 300,000 annual deaths worldwide due to failure of current therapies. The natural killer group 2D (NKG2D) receptors on natural killer (NK) cells and several T cell subsets play an important role for immunosurveillance of HNSCC and are thus targeted by tumor immune evasion strategies in particular by shedding of various NKG2D ligands (NKG2DLs). Based on plasma and tumor samples of 44 HNSCC patients, we found that despite compositional heterogeneity the total plasma level of NKG2DLs correlates with NK cell inhibitio…

medicine.medical_treatmentT cellImmunologyadsorption apheresisimmunotherapy of cancerBiologynatural killer group 2D ligandshead and neck squamous cell carcinomaNatural killer cell03 medical and health sciencestumor immune escape0302 clinical medicineCancer immunotherapymedicineImmunology and AllergyOriginal ResearchLymphokine-activated killer cellnatural killer cellsNKG2Dmedicine.diseasePrimary tumorHead and neck squamous-cell carcinomaImmunosurveillancestomatognathic diseasesmedicine.anatomical_structure030220 oncology & carcinogenesisImmunology030215 immunologyFrontiers in Immunology
researchProduct

Ētikas diskursi par "oligarhu sarunām" un to publicēšanu Latvijas latviešu valodā rakstošajos medijos

2018

“Oligarhu sarunu” publicēšana žurnālā “Ir” 2017. gada 15. jūnijā Latvijas publiskajā telpā aktualizēja diskusiju par sarunās iesaistīto pušu ētisko atbildību šajā notikumā. Pētījuma “Ētikas diskursi par "oligarhu sarunām" un to publicēšanu Latvijas latviešu valodā rakstošajos medijos” mērķis ir atklāt ētikas diskursus ziņu portālu Irir.lv, NRA.lv, Diena.lv, LA.lv publikācijās laika periodā no 2017. gada 15. jūnija līdz 20. jūlijam. Pētījuma jautājums ir – kādi ētikas diskursi tiek veidoti Irir.lv, NRA.lv, Diena.lv, LA.lv publikācijās par “oligarhu sarunām” un to publicēšanu? Darba teorētiskajā daļā apzināts ētikas jēdziens un teorijas, lai pēc tam, izmantojot kvantitatīvās kontentanalīzes u…

medijiētikaziņu portāliKomunikācijas zinātnediskurssoligarhu sarunas
researchProduct

Multiplex Ligation-dependent Probe Amplification analysis of Copy Number Variants in mentally retarded patients

2011

The aetiology of mental retardation and dysmorphism is still poorly understood in over half of the affected individuals. Recent studies have shown that genomic mutations such as Copy Number Variants (CNV) can be important factors predisposing to the highly heterogeneous clinical conditions observed in affected individuals. Genome−wide array−Comparative Genomic Hybridization (aCGH) is the best technology available so far for a first screening of CNVs in genomic DNA in patients and control individuals. However, CNVs detected by aCGH need validation by an independent method such as Multiplex Ligation-dependent Probe Amplification (MLPA). In this report we present the results of a MLPA analysis…

mentallySettore BIO/13 - Biologia ApplicataLigation-dependentretarded patient
researchProduct

CD40 activity on mesenchymal cells negatively regulates OX40L to maintain bone marrow immune homeostasis under stress conditions

2021

BackgroundWithin the bone marrow (BM), mature T cells are maintained under homeostatic conditions to facilitate proper hematopoietic development. This homeostasis depends upon a peculiar elevated frequency of regulatory T cells (Tregs) and immune regulatory activities from BM-mesenchymal stem cells (BM-MSCs). In response to BM transplantation (BMT), the conditioning regimen exposes the BM to a dramatic induction of inflammatory cytokines and causes an unbalanced T-effector (Teff) and Treg ratio. This imbalance negatively impacts hematopoiesis, particularly in regard to B-cell lymphopoiesis that requires an intact cross-talk between BM-MSCs and Tregs. The mechanisms underlying the ability of…

mesenchymal cellAdultMaleCancer ResearchTransplantation ConditioningT cellbone marrow transplantationImmunologyBone Marrow CellsOX40 LigandBiologySettore MED/08 - Anatomia PatologicaLymphocyte ActivationMesenchymal Stem Cell TransplantationT-Lymphocytes RegulatoryMiceYoung AdultImmune systemBone MarrowStress PhysiologicalmedicineCD40AnimalsHomeostasisHumansImmunology and AllergyLymphopoiesisCD40 AntigensOriginal ResearchAgedCD40B-cell developmentMesenchymal Stem Cellshemic and immune systemsRC581-607Middle AgedOX40LCell biologyTransplantationHaematopoiesismedicine.anatomical_structureGene Expression Regulationbiology.proteinFemaleBone marrowImmunologic diseases. AllergyStem cellB-cell developmentbone marrow transplantation CD40 mesenchymal cell OX40L
researchProduct